Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21
Phase 31

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04227106Phase 3Completed
Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa
PrincipalinvestigatorStart date: 2020-01-10
NCT01791894Phase 1/2Completed
Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma
Basal Cell Carcinoma of the SkinRecurrent Skin Cancer
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sarah Abdelwahab, MD

Abeona Therapeutics, Inc

Related
2 trials

Shared therapeutic areas:

Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa

Worked with same sponsors:

Abeona Therapeutics, Inc
Similarity Score15%

Angela Iheanacho, MS

Abeona Therapeutics, Inc

Related
2 trials

Shared therapeutic areas:

Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa

Worked with same sponsors:

Abeona Therapeutics, Inc
Similarity Score15%

Matt P Marinkovich, MD

Associate Professor of Dermatology

Related
2 trials

Shared therapeutic areas:

Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa
Similarity Score15%

Amy S Paller, MD

Northwestern University

Related
4 trials

Shared therapeutic areas:

Epidermolysis Bullosa
Similarity Score8%

Jean Y Tang, PhD

Stanford University

Related
1 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa

Worked with same sponsors:

Stanford University
Similarity Score8%

Alexander Colevas

Stanford University

Related
2 trials

Shared therapeutic areas:

Recurrent Skin Cancer

Worked with same sponsors:

Stanford University
Similarity Score8%

Sarah Chaumon

Assistance Publique - Hôpitaux de Paris

Related
1 trials

Shared therapeutic areas:

Epidermolysis Bullosa
Similarity Score8%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Epidermolysis Bullosa
Similarity Score8%

Elena Pope, MD, FRCPC

The Hospital for Sick Children

Related
1 trials

Shared therapeutic areas:

Recessive Dystrophic Epidermolysis Bullosa
Similarity Score8%

Elena Pope, MD

The Hospital for Sick Children

Related
4 trials

Shared therapeutic areas:

Epidermolysis Bullosa
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04227106Phase 3PrincipalInvestigator

Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa
Completed
NCT01791894Phase 1/2PrincipalInvestigator

Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma

Basal Cell Carcinoma of the SkinRecurrent Skin Cancer
Completed

All 2 trials loaded